(MedPage Today) — ORLANDO — More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 weeks of treatment with an investigational dual-target small-molecule inhibitor, according to a study… Source link : https://www.medpagetoday.com/meetingcoverage/aad/114634 Author : Publish date : 2025-03-13 16:28:00 Copyright for syndicated content belongs to the […]
The post Rapid Improvement in Atopic Dermatitis With Dual JAK/TYK2 Inhibitor first appeared on News Health.
Author : News Health
Publish date : 2025-03-13 16:28:00
Copyright for syndicated content belongs to the linked Source.